Morgan W - Search Results

1

Effect of choice of reference equation on analysis of pulmonary function in cystic fibrosis patients.

Rosenfeld M, Pepe MS, Longton G, Emerson J, FitzSimmons S, Morgan W. Rosenfeld M, et al. Among authors: morgan w. Pediatr Pulmonol. 2001 Mar;31(3):227-37. doi: 10.1002/ppul.1033. Pediatr Pulmonol. 2001. PMID: 11276136

2

A scoring system for lung function tests in infants.

Hampton F, Beardsmore CS, Morgan W, Williams A, Taussig L, Thompson JR. Hampton F, et al. Among authors: morgan w. Pediatr Pulmonol. 1992 Nov;14(3):149-55. doi: 10.1002/ppul.1950140303. Pediatr Pulmonol. 1992. PMID: 1480440

3

Circulating levels of tumor necrosis factor and interleukin-1 in cystic fibrosis.

Brown MA, Morgan WJ, Finley PR, Scuderi P. Brown MA, et al. Among authors: morgan wj. Pediatr Pulmonol. 1991;10(2):86-91. doi: 10.1002/ppul.1950100209. Pediatr Pulmonol. 1991. PMID: 2030926

4

Infants with upper respiratory illnesses have significant reductions in maximal expiratory flow.

Martinez FD, Taussig LM, Morgan WJ. Martinez FD, et al. Among authors: morgan wj. Pediatr Pulmonol. 1990;9(2):91-5. doi: 10.1002/ppul.1950090206. Pediatr Pulmonol. 1990. PMID: 2399052

5

Partial expiratory flow-volume curves in infants and young children.

Morgan WJ, Geller DE, Tepper RS, Taussig LM. Morgan WJ, et al. Pediatr Pulmonol. 1988;5(4):232-43. doi: 10.1002/ppul.1950050410. Pediatr Pulmonol. 1988. PMID: 3070472 Review. No abstract available.

6

Pulmonary function in infants and children.

Pfaff JK, Morgan WJ. Pfaff JK, et al. Among authors: morgan wj. Pediatr Clin North Am. 1994 Apr;41(2):401-23. doi: 10.1016/s0031-3955(16)38724-7. Pediatr Clin North Am. 1994. PMID: 8139882 Review.

7

Markers and mediators of inflammation in neonatal lung disease.

Ozdemir A, Brown MA, Morgan WJ. Ozdemir A, et al. Among authors: morgan wj. Pediatr Pulmonol. 1997 Apr;23(4):292-306. doi: 10.1002/(sici)1099-0496(199704)23:4<292::aid-ppul7>3.0.co;2-o. Pediatr Pulmonol. 1997. PMID: 9141115 Review. No abstract available.

8

Estimating effectiveness in an observational study: a case study of dornase alfa in cystic fibrosis. The Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

Johnson CA, Butler SM, Konstan MW, Breen TJ, Morgan WJ. Johnson CA, et al. Among authors: morgan wj. J Pediatr. 1999 Jun;134(6):734-9. doi: 10.1016/s0022-3476(99)70290-8. J Pediatr. 1999. PMID: 10356143 Clinical Trial.

9

Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada.

Morgan WJ, Butler SM, Johnson CA, Colin AA, FitzSimmons SC, Geller DE, Konstan MW, Light MJ, Rabin HR, Regelmann WE, Schidlow DV, Stokes DC, Wohl ME, Kaplowitz H, Wyatt MM, Stryker S. Morgan WJ, et al. Pediatr Pulmonol. 1999 Oct;28(4):231-41. doi: 10.1002/(sici)1099-0496(199910)28:4<231::aid-ppul1>3.0.co;2-2. Pediatr Pulmonol. 1999. PMID: 10497371

10

Patterns of medical practice in cystic fibrosis: part I. Evaluation and monitoring of health status of patients. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

Konstan MW, Butler SM, Schidlow DV, Morgan WJ, Julius JR, Johnson CA. Konstan MW, et al. Among authors: morgan wj. Pediatr Pulmonol. 1999 Oct;28(4):242-7. doi: 10.1002/(sici)1099-0496(199910)28:4<242::aid-ppul2>3.0.co;2-w. Pediatr Pulmonol. 1999. PMID: 10497372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results